Fresenius stock trades at EUR 46.115 with EUR 25.93 billion cap

Published on 09/25/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius stock posted EUR 5,864 million in Q2/2026 revenue, up 6 percent year over year. UBS maintained a EUR 56 target on September 17, 2026.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht — Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius (ISIN DE0005785604) stock was trading at EUR 46.115 on Xetra on September 25, 2026, up 0.83 percent from the previous close of EUR 45.735. The market capitalization stood at EUR 25.93 billion, giving the latest move a clear valuation context.

Q2 revenue reaches EUR 5,864 million

In its Q2/2026 investor update, Fresenius reported revenue of EUR 5,864 million, an organic increase of 6 percent from Q2/2025. EBIT before special items rose 10 percent in constant currency to EUR 719 million, while core EPS increased 14 percent to EUR 0.83.

The Q2 figures show why earnings quality matters more than the daily share move. Fresenius reported a 12.3 percent EBIT margin in Q2/2026, an improvement of 60 basis points from the prior-year quarter.

UBS keeps EUR 56 target

According to MarketScreener on September 17, 2026, UBS analyst Graham Doyle maintained a Buy rating and a EUR 56 target for Fresenius. The target is EUR 9.885 above the September 25 price, equivalent to 21.43 percent above the Xetra quote.

A company announcement republished by TradingView on August 4, 2026, showed that Fresenius raised its fiscal-year 2026 constant-currency core EPS growth guidance to 10 percent to 15 percent from 5 percent to 10 percent. That revision followed the Q2 performance and provides the main earnings reference for the stock.

EUR 46.115 on Xetra

Fresenius stock was trading at EUR 46.115 on Xetra on September 25, 2026. The intraday range was EUR 45.845 to EUR 46.233, while the 52-week range stood at EUR 35.110 to EUR 52.960.